Both clinical and experimental studies have shown that changes in the abundance of insulin signalling molecules in skeletal muscle and adipose tissue precede the development of insulin resistance and type 2 diabetes mellitus (T2DM) [26-29]. The gene discussed is INS; the disease is type 2 diabetes mellitus.